Monte Rosa Therapeutics, Inc. (GLUE) Insider Trading

Name: Monte Rosa Therapeutics, Inc. (GLUE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 17, 2026): Warmuth Markus (President & CEO): Sale of 9,500 shares, $220.2K.

Get alerted when insiders trade GLUE

Email address

Loading company data...

Beta

Loading company details...

Beta